SCHEMBL4856797

SCHEMBL4856797

CN(c1ccccn1)c1c(SC(F)F)c(C#N)nn1-c1c(Cl)cc(C(F)(F)F)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA2 P47869 20/20 0.43
GABRB2 P47870 20/20 0.43
GABRP O00591 19/20 0.43
GABRD O14764 19/20 0.43
GABRA1 P14867 19/20 0.43
GABRB1 P18505 19/20 0.43
GABRG2 P18507 19/20 0.43
GABRB3 P28472 19/20 0.43
GABRA5 P31644 19/20 0.43
GABRA3 P34903 19/20 0.43
GABRA4 P48169 19/20 0.43
GABRE P78334 19/20 0.43
GABRA6 Q16445 19/20 0.43
GABRG1 Q8N1C3 19/20 0.43
GABRG3 Q99928 19/20 0.43
GABRQ Q9UN88 19/20 0.43
NR1I2 O75469 1/20 0.43
LMNA P02545 1/20 0.43
CYP3A4 P08684 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyriprole SCHEMBL29422238 0.77 GABRP (0.41) GABRA2GABRB2GABRPGABRDGABRA1
Pyriprole SCHEMBL27011 0.77 GABRP (0.41) GABRA2GABRB2GABRPGABRDGABRA1
SCHEMBL5220485 0.77 GABRB3 (0.42) GABRA2GABRB2GABRPGABRDGABRA1
SCHEMBL4852569 0.77 GABRB3 (0.41) GABRA2GABRB2GABRPGABRDGABRA1
SCHEMBL5213689 0.75 GABRB3 (0.43) GABRA2GABRB2GABRPGABRDGABRA1
SCHEMBL6055709 0.75 GABRP (0.62) GABRA2GABRB2GABRPGABRDGABRA1
SCHEMBL7032071 0.73 GABRB3 (0.53) GABRA2GABRB2GABRPGABRDGABRA1
SCHEMBL4854537 0.72 GABRB3 (0.43) GABRA2GABRB2GABRPGABRDGABRA1
SCHEMBL6055815 0.72 GABRB3 (0.47) GABRA2GABRB2GABRPGABRDGABRA1
SCHEMBL9167863 0.70 GABRB3 (0.53) GABRA2GABRB2GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371768-B2 Pyrazol derivatives, pest control agent comprising the same as active ingredient, and process for producing the same NIHON NOHYAKU CO., LTD. (JP) 2008-05-13 US claimed
US-7371768-B2 Pyrazol derivatives, pest control agent comprising the same as active ingredient, and process for producing the same NIHON NOHYAKU CO., LTD. (JP) 2008-05-13 US disclosed
EP-1310497-B1 PYRAZOLE DERIVATIVE, PEST CONTROL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT AND PROCESS FOR PRODUCING THE SAME NIHON NOHYAKU CO LTD (JP) 2006-03-01 EP disclosed
US-20040053969-A1 Pyrazol derivatives, pest control agent comprising the same as active ingredient, and process for producing the same NIHON NOHYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1310497-A1 PYRAZOLE DERIVATIVES, PEST CONTROLLERS CONTAINING THE SAME AS THE ACTIVE INGREDIENT AND PROCESS FOR THEIR PRODUCTION Nihon Nohyaku Co., Ltd. (JP) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053969-A1 Pyrazol derivatives, pest control agent comprising the same as active ingredient, and process for producing the same CTRL, AADAC, CBR3 GABRA2 3104/4885GABRB2 2624/4885GABRP 1762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.